Evidence map›Paper›PMID 31926553›Full record

ArticleJournal of neuroinflammation2020

Lipopolysaccharide induces neuroinflammation in microglia by activating the MTOR pathway and downregulating Vps34 to inhibit autophagosome formation.

Xiaoxia Ye, Mingming Zhu, Xiaohang Che, Huiyang Wang, Xing-Jie Liang, Chunfu Wu, Xue Xue, Jingyu Yang

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed
14.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 191 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Control of microglial dynamics by the Arp2/3 complex and the autism- and schizophrenia-associated protein CYFIP1.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Autophagy andFrontiers in cellular and infection microbiology · 2026
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Xiaoxia YeDepartment of Pharmacology, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China.
Mingming ZhuDepartment of Pharmacology, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China.
Xiaohang CheDepartment of Pharmacology, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China.
Huiyang WangDepartment of Pharmacology, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China.
Xing-Jie LiangCAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology of China, Beijing, People's Republic of China.
Chunfu WuDepartment of Pharmacology, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China.
Xue XueState Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, 300071, People's Republic of China. xuexue@nankai.edu.cn.
Jingyu YangDepartment of Pharmacology, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China. yangjingyu2006@gmail.com.ORCID http://orcid.org/0000-0002-2791-5281
Shenyang Pharmaceutical University · CNNankai University · CNNational Center for Nanoscience and Technology · CN

Funding

National Key Research and Development Program of China 2018YFA0209800National Natural Science Foundation of China 81701829 and 31771031
6 · The paper itself

Abstract

backgroundMicroglial activation is a prominent feature of neuroinflammation, which is present in almost all neurodegenerative diseases. While an initial inflammatory response mediated by microglia is considered to be protective, excessive pro-inflammatory response of microglia contributes to the pathogenesis of neurodegeneration. Although autophagy is involved in the suppression of inflammation, its role and mechanism in microglia are unclear.

methodsIn the present study, we studied the mechanism by which lipopolysaccharide (LPS) affects microglial autophagy and the effects of autophagy on the production of pro-inflammatory factors in microglial cells by western blotting, immunocytochemistry, transfection, transmission electron microscopy (TEM), and real-time PCR. In a mouse model of neuroinflammation, generated by intraventricular injection of LPS (5 μg/animal), we induced autophagy by rapamycin injection and investigated the effects of enhanced autophagy on microglial activation by enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry.

resultsWe found that autophagic flux was suppressed in LPS-stimulated N9 microglial cells, as evidenced by decreased expression of the autophagy marker LC3-II (lipidated form of MAP1LC3), as well as increased levels of the autophagy adaptor protein SQSTM1. LPS significantly decreased Vps34 expression in N9 microglial cells by activating the PI3KI/AKT/MTOR pathway without affecting the levels of lysosome-associated proteins and enzymes. More importantly, overexpression of Vps34 significantly enhanced the autophagic flux and decreased the accumulation of SQSTM1 in LPS-stimulated N9 microglial cells. Moreover, our results revealed that an LPS-induced reduction in the level of Vps34 prevented the maturation of omegasomes to phagophores. Furthermore, LPS-induced neuroinflammation was significantly ameliorated by treatment with the autophagy inducer rapamycin both in vitro and in vivo.

conclusionsThese data reveal that LPS-induced neuroinflammation in N9 microglial cells is associated with the inhibition of autophagic flux through the activation of the PI3KI/AKT/MTOR pathway, while enhanced microglial autophagy downregulates LPS-induced neuroinflammation. Thus, this study suggests that promoting the early stages of autophagy might be a potential therapeutic approach for neuroinflammation-associated diseases.

Indexed as

AnimalsAutophagosomesAutophagyCell LineClass III Phosphatidylinositol 3-KinasesDown-RegulationInflammationLipopolysaccharidesMaleMiceMice, Inbred C57BLMicrogliaRatsRats, Sprague-DawleySignal TransductionTOR Serine-Threonine KinasesClass III Phosphatidylinositol 3-KinasesLipopolysaccharidesTOR Serine-Threonine KinasesAutophagyLipopolysaccharideMicrogliaMTORNeuroinflammationVps34

Identifiers

PMID31926553
PMCPMC6954631
OpenAlexW3003308204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.